SCHEMBL8735762

SCHEMBL8735762

CS(=O)(=O)OC(=O)c1cn(-c2ccc(F)cc2F)c2nc(N3CC4C(N)C4C3)c(F)cc2c1=O

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.79
KDM4E B2RXH2 2/20 0.79
HSD17B10 Q99714 2/20 0.79
ALDH1A1 P00352 1/20 0.79
POLB P06746 1/20 0.79
HPGD P15428 1/20 0.79
XBP1 P17861 1/20 0.79
NFKB1 P19838 1/20 0.79
HTT P42858 1/20 0.79
NFKB2 Q00653 1/20 0.79
RELA Q04206 1/20 0.79
EPHA2 P29317 1/20 0.75
FLT4 P35916 1/20 0.75
GSK3B P49841 1/20 0.75
RARB P10826 1/20 0.75
TBXAS1 P24557 1/20 0.75
SLC6A3 Q01959 1/20 0.75
KMT2A Q03164 2/20 0.61
DPP4 P27487 6/20 0.42
ABCC4 O15439 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trovafloxacin SCHEMBL29711203 0.88 LMNA (1.00) LMNAKDM4EHSD17B10ALDH1A1POLB
Trovafloxacin SCHEMBL2222007 0.88 LMNA (1.00) LMNAKDM4EHSD17B10ALDH1A1POLB
Trovafloxacin SCHEMBL29711214 0.88 LMNA (1.00) LMNAKDM4EHSD17B10ALDH1A1POLB
Trovafloxacin SCHEMBL40874 0.88 LMNA (1.00) LMNAKDM4EHSD17B10ALDH1A1POLB
Trovafloxacin SCHEMBL40875 0.88 LMNA (1.00) LMNAKDM4EHSD17B10ALDH1A1POLB
Trovafloxacin SCHEMBL8963965 0.88 LMNA (1.00) LMNAKDM4EHSD17B10ALDH1A1POLB
Trovafloxacin SCHEMBL1229500 0.88 LMNA (0.98) LMNAKDM4EHSD17B10ALDH1A1POLB
SCHEMBL7610008 0.88 EPHA2 (0.77) LMNAKDM4EHSD17B10ALDH1A1POLB
Trovafloxacin SCHEMBL8561863 0.88 LMNA (0.98) LMNAKDM4EHSD17B10ALDH1A1POLB
SCHEMBL7610001 0.88 EPHA2 (0.77) LMNAKDM4EHSD17B10ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676199-B1 Use of trovafloxacin or derivatives thereof for the manufacture of a medicament for the treatment of H. pylori infections PFIZER (US) 1998-09-02 EP disclosed
EP-0676199-A1 Use of trovafloxacin or derivatives thereof for the manufacture of a medicament for the treatment of H. pylori infections PFIZER INC. (US) 1995-10-11 EP disclosed